Latest Breaking News On - Medical plant - Page 2 : comparemela.com

Emerald Health Therapeutics, Inc.: Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update 11,740 (1,022 10,983 Recreational Recreational 287 Emerald EBITDA is calculated by subtracting realized and unrealized changes in fair value of biological assets, and adding back depreciation, share-based payments, impairment of assets, and inventories written down to Loss from operations. Emerald s audited annual consolidated financial statements and management discussion and analysis for the 12 months ended December 31, 2020, together with other information related to Emerald, including Emerald s most recent annual information form, can be found on SEDAR. Additional information related to Emerald is available on its website at www.emeraldhealth.ca.

United statesUnited kingdomBritish columbiaRiaz bandaliSwedish medicines agencyBritish columbia newsfile corpProduct developmentEmerald health therapeutics incInternational distributionRegulation services providerVenture exchangeHealth therapeuticsChief executive officerPure sunfarmsYear end financialsOperational metrics